FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...

COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...

While researchers don’t currently know why women are at greater risk of long COVID, differences in the way men’s and women’s ...

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient ...

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

On January 17, 2025, the US Federal Trade Commission (FTC) released the preliminary observations and findings from its ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Wildlife researchers Tanya Diamond and Ahíga Sandoval at Pathways for Wildlife were initially met with worry after viewing ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

The initial version of the federal government’s first “national nature assessment” was expected to be made public soon.